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Abstract Thrombin has been shown to inhibit skeletal muscle
differentiation. However, the mechanisms by which thrombin
represses myogenesis remain unknown. Since the thrombin
receptor couples to Gi, Gq=11 and G12, we examined which
subunits of heterotrimeric guanine nucleotide-binding regulatory
proteins (GKi, GKq=11, GK12 or GLQ) participate in the thrombin-
induced inhibition of C2C12 myoblast differentiation. GKi2 and
GK11 had no inhibitory effect on the myogenic differentiation.
GK12 prevented only myoblast fusion, whereas GLQ inhibited both
the induction of skeletal muscle-specific markers and the
myotube formation. In addition, the thrombin-induced reduction
of creatine kinase activity was blocked by the C-terminal peptide
of L-adrenergic receptor kinase, which is known to sequester free
GLQ. These results suggest that the thrombin-induced inhibition
of muscle differentiation is mainly mediated by GLQ.
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1. Introduction
Skeletal muscle di¡erentiation is a multistep process that
involves the commitment of mesodermal precursor cells to
the skeletal muscle lineage, the withdrawal of myoblasts
from the cell cycle and the fusion of myoblasts into multi-
nucleated myotubes. These stages are driven by the myogenic
basic helix-loop-helix (bHLH) factors that include MyoD,
myogenin, Myf5 and MRF4, as well as the myocyte enhancer
factor-2. These factors induce the expression of several skel-
etal muscle-speci¢c genes such as creatine kinase and myosin
heavy chain (MHC). Additionally, the irreversible cell cycle
arrest is controlled by the induction of cyclin-dependent ki-
nase inhibitor p21CIP1=WAF1 [1^3]. The ability of myoblasts to
di¡erentiate is negatively regulated by several growth factors
including basic ¢broblast growth factor (FGF) 2 and trans-
forming growth factor L1 [1^3]. In addition to them, it has
been reported that heterotrimeric guanine nucleotide-binding
regulatory protein (G protein)-coupled receptor agonists such
as thrombin [4^7] and lysophosphatidic acid [8] inhibit skel-
etal muscle cell di¡erentiation.
Several lines of evidence have suggested that thrombin plays
an important role in skeletal muscle development. It has been
shown that thrombin is involved in synapse elimination occur-
ring at the neuromuscular junction during muscle develop-
ment [9,10]. In addition, thrombin causes a delay in skeletal
myogenesis [4^7]. The thrombin receptor is expressed in cul-
tured myoblasts and its expression decreases once the myo-
blasts fuse to form multinucleated myotubes [5]. Thrombin
has been reported to act as a mitogen in myoblasts as well
as ¢broblasts and smooth muscle cells, and induce their pro-
liferation [4,5]. In contrast, it has been reported that thrombin
does not induce a mitogenic signal in myoblastic cell line [6],
and that it inhibits myoblast apoptosis and functions as a
survival factor for myoblasts [7].
Thrombin receptor, which is a member of the G protein-
coupled receptor family, is activated by cleavage of its N-
terminal extracellular domain with thrombin. The new N-ter-
minus generated by this proteolysis acts as a tethered ligand
for the receptor [11,12]. G proteins are composed of K, L and
Q subunits, and mammalian G proteins are grouped into four
subfamilies : Gs, Gi, Gq and G12 [13^15]. Activation of the
thrombin receptor leads to inhibition of adenylyl cyclase and
activation of phospholipase CL through coupling to Gi and
Gq=11, respectively [16]. The receptor also couples to G12 in
platelets [17] and in Sf9 cells expressing the receptor and GK12
[18].
In this study, we investigated which subunits of G proteins
are involved in thrombin-induced repression of myogenic dif-
ferentiation using the transient expression of GKi2, GK11,
GK12 and GLQ in mouse myogenic C2C12 cells. Our results
suggest that the thrombin-induced inhibition of myoblast dif-
ferentiation is mainly mediated by GLQ.
2. Materials and methods
2.1. Materials
Rabbit polyclonal antibody against GKi1=2 was generously provided
by T. Asano (Institute for Developmental Research, Aichi Human
Service Center, Kasugai, Japan). Rabbit polyclonal antibodies against
GK11 (D-17) and GL (T-20) were purchased from Santa Cruz Bio-
technology. Rabbit polyclonal antibody against GK12 and mouse
monoclonal antibody against myogenin (F5D) were obtained from
Calbiochem and Pharmingen, respectively. Mouse monoclonal anti-
body against MHC was obtained from Chemicon International.
Mouse monoclonal antibody against c-Myc epitope (9E10) was pur-
chased from BAbCO. Anti-mouse and anti-rabbit Ig antibodies con-
jugated with horseradish peroxidase were from New England Bio-
Labs. Thrombin and Hoechst 33342 were obtained from Sigma.
2.2. Plasmids
Complementary DNAs encoding rat GKi2 [19], mouse GK11 [20]
and rat GK12 [21], and Myc epitope-tagged L-adrenergic receptor ki-
nase C-terminal peptide (LARKct) [22] were prepared as described
previously. Constitutively activated mutants of GKi2 (GKi2Q205L),
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GK11 (GK11Q209L) and GK12 (GK12Q229L) were made by primer-
mediated mutagenesis. Bovine GL1 and GQ2 cDNAs were generously
provided by M.I. Simon (California Institute of Technology, Pasade-
na, CA, USA) and T. Nukada (Tokyo Institute of Psychiatry, Tokyo,
Japan), respectively. RhoA and Rac1 cDNAs were generously pro-
vided by K. Kaibuchi (Nara Institute of Science and Technology,
Ikoma, Japan). Cdc42Hs cDNA was kindly provided by R.A. Cerione
(Cornell University, Ithaca, NY, USA). RhoA(T19N), Rac1(T17N)
and Cdc42Hs(T17N) were made by oligonucleotide-directed mutagen-
esis. C-terminal Src kinase (Csk) and H-Ras(S17N) cDNAs were gen-
erous gifts from M. Okada (Institute for Protein Research, Osaka
University, Osaka, Japan) and G.M. Cooper (Dana-Farber Cancer
Institute, Boston, MA, USA), respectively. All cDNAs were sub-
cloned into mammalian expression vector pCMV5. The isolated
cDNAs and the mutations were con¢rmed by dideoxynucleotide se-
quencing.
2.3. Cell culture and transfection
Mouse myoblast cell line C2C12 was maintained in Dulbecco’s
modi¢ed Eagle’s medium (DMEM) (Sigma) containing 15% fetal bo-
vine serum (Life Technologies), 50 U/ml penicillin and 100 Wg/ml
streptomycin (growth medium, GM). The cells were cultured at
37‡C in a humidi¢ed 10% CO2 environment. Di¡erentiation of the
cells was induced at 80^90% con£uence by changing the culture me-
dium from GM to DMEM containing 2% horse serum (Life Tech-
nologies) and antibiotics (di¡erentiation medium, DM). Transfection
was performed using LipofectAMINE Plus reagent (Life Technolo-
gies) in serum-free medium according to the manufacturer’s instruc-
tions. At 2 h after transfection, the medium was changed from serum-
free medium to GM. After a 24 h incubation in GM, the cells were
transferred to DM.
2.4. Creatine kinase assay
The cells were washed twice with phosphate-bu¡ered saline and
lysed in lysis bu¡er (20 mM HEPES^NaOH (pH 7.5), 5 mM MgCl2,
150 mM NaCl, 1 Wg/ml aprotinin, 1 Wg/ml leupeptin, 1 mM EGTA,
1 mM EDTA, 1 mM Na3VO4, 10 mM NaF, 25 mM L-glycerophos-
phate, 10% glycerol and 0.5% Triton X-100) on ice. The cell lysates
were centrifuged at 15 000 rpm for 10 min at 4‡C and the supernatants
were used for creatine kinase assay. Creatine kinase activity was meas-
ured with a creatine kinase assay kit (Sigma) and the activity was
normalized to protein content, which was determined by the Bradford
method with bovine serum albumin as standard protein.
2.5. Evaluation of myoblast fusion
The cells were rinsed twice with phosphate-bu¡ered saline and ¢xed
with 3% paraformaldehyde in phosphate-bu¡ered saline at room tem-
perature. After staining with Hoechst 33342, nuclei were counted and
the fusion index (%) was calculated. Fusion index (%) = (number of
nuclei in myotubes/total number of nuclei in both myoblasts and
myotubes)U100.
2.6. Immunoblot analysis
Cell lysates were boiled in sodium dodecyl sulfate (SDS) sample
bu¡er. The boiled samples were resolved by SDS^PAGE and trans-
ferred to nitrocellulose membranes. The membranes were blocked
using 1% bovine serum albumin in phosphate-bu¡ered saline contain-
ing 0.1% Tween 20 and incubated with each speci¢c antibody. Immu-
noreactive bands were visualized by using secondary horseradish per-
oxidase-conjugated antibodies and chemiluminescence (NEN Life
Science Products).
3. Results
3.1. Thrombin has an inhibitory e¡ect on myoblast
di¡erentiation
To clarify the involvement of G proteins in skeletal myo-
genesis, we ¢rst examined the e¡ect of thrombin on C2C12
cell di¡erentiation. C2C12 myoblasts were grown to near con-
£uence in GM and then shifted to DM in the absence or the
presence of thrombin. In the absence of thrombin, myotube
formation typically began 2^3 days following the replacement
of medium, whereas the myoblast fusion was markedly inhib-
ited in the thrombin-treated cells (Fig. 1A). We next examined
whether thrombin a¡ects the induction of muscle di¡erentia-
tion markers such as creatine kinase and myogenin. The in-
duction of creatine kinase and the expression of myogenin
were signi¢cantly reduced by thrombin (Fig. 1B,C). These
results indicate that thrombin blocks the myoblast di¡erentia-
tion.
3.2. Inhibitory e¡ect of thrombin on the induction of muscle cell
di¡erentiation markers is mediated by GLQ
Since it has been shown that the thrombin receptor couples
to Gi, Gq=11 and G12 [16^18], we investigated which subunits
of G proteins (GKi, GKq=11, GK12 or GLQ) are implicated in
the thrombin-induced inhibition of C2C12 cell di¡erentiation
using the transient expression of each subunit. In C2C12 my-
oblasts, endogenous GKi2, GK11 and GK12 were expressed
(Fig. 2A). Although the expression of the thrombin receptor
has been shown to decrease during cell di¡erentiation [5], the
expression levels of endogenous GKi2, GK11, GK12 and GLQ
did not change up to 7 days after induction of di¡erentiation
(data not shown). The cells were transfected with wild-type
GKi2, GK11 and GK12, constitutively activated mutants of
GKi2 (GKi2Q205L), GK11 (GK11Q209L) and GK12
(GK12Q229L), or GLQ. Lysates of the transfected cells were
resolved by SDS^PAGE and the expression of these proteins
was detected by immunoblotting using each speci¢c antibody.
Fig. 1. E¡ect of thrombin on C2C12 cell di¡erentiation. A: C2C12
myoblasts were grown to 80^90% con£uence and then induced to
di¡erentiate for 2 days in the absence or the presence of 1 U/ml
thrombin. Phase-contrast photomicrographs of representative ¢elds
are shown. B: Myoblasts (Mb) were di¡erentiated with DM in the
absence or the presence of 1 U/ml thrombin and creatine kinase ac-
tivity was measured at the times indicated. Values represent the
mean þ S.E.M. from at least three independent experiments. C:
Western blot analysis of myogenin expression in myoblasts (Mb) or
myoblasts cultured in DM for the times indicated in the absence or
the presence of 1 U/ml thrombin.
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Each GK and GL were overexpressed in the transfected cells
(Fig. 2A). Wild-type GKi2, GKi2Q205L, wild-type GK12 and
GK12Q229L did not exhibit any signi¢cant e¡ect on the crea-
tine kinase induction as compared to control experiment with
Mock-transfected cells (Fig. 2B). Interestingly, wild-type
GK11, but not GK11Q209L, potentiated the induction slightly
(Fig. 2B). In contrast, GLQ suppressed the induction of crea-
tine kinase activity (Fig. 2B). To con¢rm the involvement of
GLQ in the inhibition of creatine kinase activity by thrombin
(Fig. 1B), we further examined the e¡ect of LARKct, which is
known to sequester free GLQ [23], on the thrombin-induced
inhibition. Expression of LARKct prevented the thrombin-in-
duced reduction of creatine kinase activity (Fig. 2C). These
results suggest that the reduction of creatine kinase activity by
thrombin is mediated by GLQ.
We next investigated the e¡ects of GKi2, GK11, GK12 and
GLQ on the expression of myogenin and MHC. In Mock-
transfected cells, the expression of myogenin and MHC was
detected at 1 day and 2 days after initiation of di¡erentiation,
respectively (Fig. 3). In agreement with the results shown in
Fig. 2B, overexpression of wild-type GKi2, GKi2Q205L, wild-
type GK12 and GK12Q229L had no signi¢cant e¡ect on the
induction of myogenin and MHC relative to control. In wild-
type GK11-transfected cells, myogenin has already been ex-
pressed under the growth condition (day 0) and MHC was
induced 1 day earlier. On the other hand, the expression of
myogenin and MHC in GLQ-transfected cells was reduced and
delayed as compared to Mock-transfected cells.
3.3. GK12 and GLQ inhibit myotube formation
We overexpressed GKi2, GK11, GK12 and GLQ in C2C12
cells and observed the morphology of myoblasts that were
induced to di¡erentiate for 4 days (Fig. 4). The ability of
wild-type GKi2-, GKi2Q205L- and GK11Q209L-transfected
cells to form multinucleated myotubes was comparable to
that of Mock-transfected cells (Fig. 4A^C,E). As expected,
wild-type GK11 accelerated myotube formation, while GLQ
delayed it (Fig. 4D,H). Unexpectedly, wild-type GK12 and
GK12Q229L had an inhibitory e¡ect on myotube fusion
(Fig. 4F,G) although they were not able to inhibit the induc-
tion of biochemical di¡erentiation markers such as creatine
kinase, myogenin and MHC (Figs. 2B and 3). In Mock-trans-
fected cells, approximately 35% of myoblast nuclei were
present in myotubes at 5 days in DM. In contrast, the fusion
index in wild-type GK12- or GK12Q229L-transfected cells was
reduced to approximately 17 or 7%, respectively. The inhib-
Fig. 2. E¡ects of GKi2, GK11, GK12 and GLQ on the induction of creatine kinase activity during C2C12 cell di¡erentiation. A: Cells were trans-
fected with an empty expression vector (Mock), the plasmid of wild-type GK (WT) or active GK (QL) (1 Wg) as indicated, or the plasmids of
GL1 (1 Wg) and GQ2 (1 Wg). Equal amounts of cell lysates were subjected to SDS^PAGE and the separated proteins were immunoblotted with
each speci¢c antibody. B: Cells were transfected with an empty expression vector (Mock), the plasmid of wild-type GK (WT) or active GK
(QL) as indicated, or the plasmids of GL1 and GQ2. Creatine kinase activity was measured at 3 days after initiation of di¡erentiation. The data
are expressed as the percent of creatine kinase activity in Mock-transfected cells. C: Cells were transfected with an empty expression vector or
the plasmid of Myc-LARKct and cultured in DM in the absence or the presence of 1 U/ml thrombin. Creatine kinase activity was measured at
2 days after initiation of di¡erentiation. The data are expressed as the percent of creatine kinase activity in Mock-transfected cells in the ab-
sence of thrombin. The expression level of Myc-LARKct was determined by immunoblotting using anti-Myc antibody. All values represent the
mean þ S.E.M. from at least three separate experiments. Mb shows myoblasts. * and ** mean P6 0.05 and P6 0.01, respectively, as compared
to Mock.
Fig. 3. E¡ects of GKi2, GK11, GK12 and GLQ on the induction of
myogenin and MHC. Cells were transfected with an empty expres-
sion vector (Mock), the plasmid of wild-type GK (KWT) or active
GK (KQL) (1 Wg) as indicated, or the plasmids of GL1 (1 Wg) and
GQ2 (1 Wg). Cell lysates were resolved by SDS^PAGE, and the ex-
pression of myogenin and MHC in myoblasts (Mb) or the trans-
fected cells was detected by immunoblotting using anti-myogenin
and anti-MHC antibodies, respectively.
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itory e¡ect of GK12Q229L on the myotube formation retained
even 7 days in DM (data not shown). We previously reported
that Rho and Src family kinase function downstream of GK12
in the signaling pathways from GK12 to JNK in HEK 293
cells [21]. In addition, several studies indicate that GK12 reg-
ulates the Rho family GTPases-dependent signaling pathways
[24^28]. Therefore, we examined the e¡ects of dominant-neg-
ative RhoA(T19N), Rac1(T17N) and Cdc42Hs(T17N), and
Csk, a cytoplasmic protein tyrosine kinase which inactivates
Src family kinases [29], on the myotube formation of
GK12Q229L-transfected cells. The expression of RhoA(T19N),
Rac1(T17N), Cdc42Hs(T17N) or Csk alone had no signi¢cant
e¡ect on the myotube formation, and the transfected cells
were able to form multinucleated myotubes (data not shown).
When the cells were coexpressed with RhoA(T19N),
Rac1(T17N), Cdc42Hs(T17N) or Csk together with
GK12Q229L, they failed to rescue the fusion defect induced
by GK12Q229L (data not shown).
4. Discussion
It has been reported that thrombin inhibits skeletal muscle
cell di¡erentiation [4^7]. In the present study, we showed that
thrombin reduced the induction of muscle di¡erentiation
markers such as creatine kinase and myogenin, and delayed
myotube formation in C2C12 cells (Fig. 1). However, the
mechanisms by which thrombin inhibits muscle di¡erentiation
have not been fully elucidated. Since the thrombin receptor
has been shown to couple to Gi, Gq=11 and G12 [16^18], we
examined which subunits of G proteins (GKi, GKq=11, GK12 or
GLQ) are involved in the thrombin-induced inhibition of
C2C12 cell di¡erentiation. GKi2 and GK12 have no apparent
e¡ect on creatine kinase induction (Fig. 2B) and the expres-
sion of myogenin and MHC (Fig. 3) as compared to control.
In contrast, wild-type GK11, but not GK11Q209L, enhanced
the creatine kinase induction (Fig. 2B) and induced the earlier
expression of myogenin and MHC (Fig. 3). Although the
regulatory mechanisms by which wild-type GK11 promotes
the induction remain to be clari¢ed at present, some of
Gq=11-coupled receptors other than the thrombin receptor
may participate in the induction of muscle cell di¡erentiation.
Since GK11Q209L failed to promote the creatine kinase induc-
tion (Fig. 2B) and the induction of myogenin and MHC (Fig.
3), the transient activation and/or deactivation of GKq=11 at
some stage during myogenesis might be required for the
muscle di¡erentiation.
GLQ repressed the creatine kinase induction (Fig. 2B) and
the expression of myogenin and MHC (Fig. 3). In addition,
LARKct, which sequesters free GLQ, blocked the thrombin-
induced attenuation of creatine kinase activity (Fig. 2C).
Moreover, the expression of GLQ, as well as thrombin, delayed
myotube formation (Figs. 1A and 4H). These data suggest
that the inhibitory e¡ect of thrombin on myogenesis is medi-
ated by GLQ. Consistent with our observation, it has been
reported that the LQ subunits of pertussis toxin-sensitive G
proteins are involved in FGF-mediated repression of myogen-
esis in mouse skeletal muscle satellite cell line MM14 [30].
However, the molecular mechanisms leading to activation of
pertussis toxin-sensitive G proteins by the stimulation of the
FGF receptor which is a receptor tyrosine kinase but not G
protein-coupled receptor remain unknown. The GLQ-mediated
signaling pathways involved in repression of myogenic di¡er-
entiation are currently under investigation.
Wild-type GK12 and GK12Q229L prevented myotube forma-
tion (Fig. 4F,G) despite no inhibitory e¡ect on the induction
of creatine kinase, myogenin and MHC (Figs. 2B and 3).
Some reports have shown that myoblast fusion is independent
of the expression of biochemical di¡erentiation markers [31^
34]. Rho, Rac and Cdc42 have been shown to be required for
myogenic di¡erentiation [35,36]. In contrast, it has recently
been reported that the transient expression of constitutively
activated Rac and Cdc42 in primary myoblasts causes the
inhibition of muscle cell di¡erentiation [37]. In Drosophila,
the expression of activated Rac in muscle precursors also dis-
rupts myoblast fusion [38]. Furthermore, it has been shown
that Src family tyrosine kinase inhibits skeletal myogenesis
[39]. However, Rho family GTPases and Src family kinase
are unlikely to participate in the GK12-mediated inhibition
of myoblast fusion since dominant-negative mutants of Rho,
Rac and Cdc42, and Csk failed to restore the GK12Q229L-
induced fusion defect (data not shown). It has been reported
that adhesion molecules including N- and M-cadherins, N-
and V-CAMs, and integrins are involved in myoblast fusion
[40]. GK12 in myoblasts may regulate these adhesion molecules
through Rho family GTPases- and Src family kinase-inde-
pendent mechanisms. Further studies are necessary to eluci-
Fig. 4. E¡ects of GKi2, GK11, GK12 and GLQ on myotube formation. Cells were transfected with an empty expression vector (Mock) (A), the
plasmid of wild-type GKi2 (B), GKi2Q205L (C), wild-type GK11 (D), GK11Q209L (E), wild-type GK12 (F) and GK12Q229L (G), or the plasmids
of GL1 and GQ2 (H), and cultured in DM for 4 days. Phase-contrast photomicrographs of representative ¢elds are shown.
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date the molecular mechanisms by which GK12 inhibits myo-
blast fusion.
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